ENDONOVO THERAPEUTICS, INC. Debt Conversion, Original Debt, Amount
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Debt Conversion, Original Debt, Amount of $100.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2023-12-29
- ENDONOVO THERAPEUTICS, INC. debt conversion, original debt, amount for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. debt conversion, original debt, amount for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. debt conversion, original debt, amount for the quarter ending 2023-03-31 was $100.00K, a 35.14% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. debt conversion, original debt, amount for the quarter ending 2022-09-30 was $120.30K.
- ENDONOVO THERAPEUTICS, INC. debt conversion, original debt, amount for fiscal 2021 was $393.60K.
- ENDONOVO THERAPEUTICS, INC. debt conversion, original debt, amount for fiscal 2014 was $268.16K.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-29 | $0.00 derived: sum of 2 quarters · filed 2023-12-29 | $100.00K 10-Q · filed 2023-12-29 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $100.00K 10-Q · filed 2023-08-21 | ||
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-22 | |||
| 2022-09-30 | $120.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-29 | $140.10K derived: sum of 2 quarters · filed 2023-12-29 | $214.10K 10-Q · filed 2023-12-29 | |
| 2022-06-30 | $19.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $93.80K 10-Q · filed 2023-08-21 | ||
| 2022-03-31 | $74.00K 10-Q · filed 2023-05-22 | |||
| 2021-12-31 | $393.60K 10-K · filed 2023-04-17 | |||
| 2014-12-31 | $268.16K 10-K · filed 2015-06-15 |